| Metric | Value (₹ Cr) | vs Q3 FY25 |
|---|---|---|
| Revenue | 1.6K | 1.4% |
| Total Income | 1.6K | 1.3% |
| Expenditure | 1.5K | 0.3% |
| PBT | 132.12 | 15.7% |
| Net Profit | 99.53 | 16.3% |
| OPM | 10.66% | 6.70pp |
| NPM | 6.11% | 1.10pp |
| EPS | 3.58 | 16.4% |
Shyam Metalics Reports Robust Revenue Growth of 15% YoY in Q4 FY25, Launched Diversified Range of Roofing Sheets, Operating EBITDA Grew by 17% YoY, Declared Final Dividend of Rs. 2.25 per Share
09 May 2025 · 9 May 2025, 05:26 pm
Summary
Shyam Metalics and Energy Limited, a leading multi-metal conglomerate, announced its financial results for the quarter and full year ended 31st March 2025. The company reported a 15% YoY growth in revenue, reaching Rs. 4,139 crores, and a 17% growth in Operating EBITDA. The company also launched a diversified range of roofing sheets under the SEL Tiger brand and declared a final dividend of Rs. 2.25 per share. Shyam Metalics also expanded its product line by entering the food-grade aluminum foil segment with the introduction of SEL Tiger Foil.
Key Highlights
- 1
Revenue grew by 15% YoY in Q4 FY25, reaching Rs. 4,139 crores
- 2
Operating EBITDA grew by 17% YoY in Q4 FY25
- 3
Launched a diversified range of roofing sheets under the SEL Tiger brand
- 4
Declared a final dividend of Rs. 2.25 per share
- 5
Expanded product line by entering the food-grade aluminum foil segment
Management Comments
Mr Brij Bhushan Agarwal
Vice Chairman & Managing Director
We are delighted to report an exceptional performance in the fourth quarter and full year of FY25. Our quarterly revenues grew by 15% YoY to %4,139 crores, while Operating EBITDA reached %515 crores, a 17% growth YoY. This impressive growth underscores the strength of our strategy and our unwavering commitment to operational excellence, even amid a challenging market landscape. We continue to expand our share in value-added products further highlighting our commitment in diversifying and fortifying our market position.
Informational and educational content only. Not investment advice.